TPST Tempest Therapeutics, Inc. logo

TPST Tempest Therapeutics, Inc.

Healthcare
$1.86+2.76%ClosedMarket Cap: $8.3M

As of 2026-05-25

Insider Statistics (Q1 2026)

Acquisitions

8

Dispositions

0

Buy/Sell Ratio

0.00

Net Shares

+668,023

Shares Acquired

668,023

Shares Disposed

0

Total Bought ($)

$1.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Apr 02Trojanowski Justinofficer: Corporate ControllerSell22,000$1.6422,000
Thu Apr 02Maestas Nicholasofficer: Chief Financial OfficerSell140,000$1.64140,000
Wed Mar 25Angel Matthewdirector, 10 percent owner, officer: CEO and PresidentBuy231,482$2.16231,482
Fri Feb 06Angel Matthewdirector, 10 percent owner, officer: CEO and PresidentSell269,621$2.38269,621
Fri Feb 06Angel Matthewdirector, 10 percent owner, officer: CEO and PresidentSell0$0.008,268,495
Wed Jan 28Simantov RonitdirectorSell1,230$2.941,230
Wed Jan 28RAAB MICHAELdirectorSell1,230$2.941,230
Wed Jan 28Pellizzari Christine AdirectorSell1,230$2.941,230
Wed Jan 28NICHOL GEOFFREYdirectorSell1,230$2.941,230
Mon Jan 06Whiting Samuelofficer: Chief Medical OfficerSell270,000$0.86270,000
Mon Jan 06Trojanowski Justinofficer: Corporate ControllerSell30,000$0.8630,000
Mon Jan 06Maestas Nicholasofficer: Chief Financial OfficerSell200,000$0.86200,000
Mon Jan 06Brady Stephen Rdirector, officer: President and CEOSell550,000$0.86550,000